These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9637199)

  • 1. Genetic and environmental risk factors in Parkinson's disease.
    Veldman BA; Wijn AM; Knoers N; Praamstra P; Horstink MW
    Clin Neurol Neurosurg; 1998 Mar; 100(1):15-26. PubMed ID: 9637199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetics and environmental factors of Parkinson disease].
    Broussolle E; Thobois S
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S11-23. PubMed ID: 12690660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and causes of Parkinson's disease].
    Lill CM; Klein C
    Nervenarzt; 2017 Apr; 88(4):345-355. PubMed ID: 28289797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkinson disease: monogenic forms and genetic susceptibility factors].
    Brice A
    Pathol Biol (Paris); 1998 Nov; 46(9):710-2. PubMed ID: 9885826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
    Taylor CA; Saint-Hilaire MH; Cupples LA; Thomas CA; Burchard AE; Feldman RG; Myers RH
    Am J Med Genet; 1999 Dec; 88(6):742-9. PubMed ID: 10581500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant Parkinson's disease and alpha-synuclein.
    Polymeropoulos MH
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S63-4. PubMed ID: 9749575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
    Di Monte DA
    Lancet Neurol; 2003 Sep; 2(9):531-8. PubMed ID: 12941575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Parkinsonism: a review.
    Vaughan JR; Davis MB; Wood NW
    Ann Hum Genet; 2001 Mar; 65(Pt 2):111-26. PubMed ID: 11427172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.
    Papapetropoulos S; Paschalis C; Athanassiadou A; Papadimitriou A; Ellul J; Polymeropoulos MH; Papapetropoulos T
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):662-5. PubMed ID: 11309462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
    Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
    Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: a test of the multifactorial etiologic hypothesis.
    Semchuk KM; Love EJ; Lee RG
    Neurology; 1993 Jun; 43(6):1173-80. PubMed ID: 8170564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into Parkinson's disease.
    Chung KK; Dawson VL; Dawson TM
    J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of genetic contributions to Parkinson's disease.
    Hofer A; Gasser T
    J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom.
    Warner TT; Schapira AH
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):378-9. PubMed ID: 9728955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Synuclein gene haplotypes are associated with Parkinson's disease.
    Farrer M; Maraganore DM; Lockhart P; Singleton A; Lesnick TG; de Andrade M; West A; de Silva R; Hardy J; Hernandez D
    Hum Mol Genet; 2001 Aug; 10(17):1847-51. PubMed ID: 11532993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
    Lotharius J; Brundin P
    Hum Mol Genet; 2002 Oct; 11(20):2395-407. PubMed ID: 12351575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.